Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
NanoMedical Systems logo — Nanotechnology Transforming Drug Delivery

NanoMedical Systems

Nanotechnology Transforming Drug Delivery

Founded 2008 United States Austin, United States 4 employees Grant Total: $10.21M Biotechnology

General Information

Company Name NanoMedical Systems
Founded Year 2008
Location United States Austin, United States +1
Employees 4
Industries Biotechnology
Funding Stage Grant
Social

Get notified when NanoMedical Systems moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NanoMedical Systems

NanoMedical Systems, founded in 2006, is pioneering the field of nanotechnology in drug delivery with its innovative nStrada™ nanofluidics platform. The company's slogan, "Nanotechnology Transforming Drug Delivery," succinctly reflects its core mission. Utilizing its proprietary technology, the company specializes in the development of advanced drug-delivery devices capable of sustained release of chronic therapies. These devices, suitable for subcutaneous implantation, can accommodate various drugs, including small molecules, peptides, and proteins. The nStrada™ devices set themselves apart from traditional polymer-based implants and depots, offering a superior performance characterized by steady-state drug concentrations within a few days and consistent release throughout the implant's duration. This stands in stark contrast to the initial burst release and prolonged timeframe for achieving steady-state concentrations associated with existing solutions. NanoMedical Systems operates within the biotechnology sector, with its headquarters located in the United States. The company secured a significant $3.00M grant investment on 14 August 2018, indicative of the industry and investor confidence in its pioneering technology. Notably, the specific investors involved in this round are not disclosed. In summary, NanoMedical Systems holds great promise in revolutionizing drug delivery through its nanofluidics platform, and its recent grant investment underscores the recognition and support the company has garnered within the industry.

Taxonomy: nanotechnology, drug delivery, nStrada™ nanofluidics platform, sustained release, chronic therapies, subcutaneous implantation, diffusion, steady-state drug concentrations, polymer-based implants, depots, small molecules, peptides, proteins, biomedical devices

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 14 Aug 2018
Venture Round •••••• - 25 May 2018
Venture Round •••••• - 12 May 2017
Venture Round •••••• - 12 Aug 2013

NanoMedical Systems Alternatives & Competitors

NanoMedical Systems vs
Thermosome
Thermosome Germany

Re-inventing tumor targeting

Grant
7 employees
Biopharma, Biotechnology
NanoMedical Systems vs
Drug Development & Delivery
Drug Development & Delivery United States

The Science & Business of Pharmaceutical and Biological Drug Development

8 employees
Health Care, Pharmaceutical
NanoMedical Systems vs
ForDoz Pharma Corp
ForDoz Pharma Corp United States

US-based sterile drug product CDMO built for scale.

30 employees
Manufacturing, Pharmaceutical

FAQ About NanoMedical Systems

Nanotechnology Transforming Drug Delivery
NanoMedical Systems was founded in 2008.
NanoMedical Systems is headquartered in Austin, United States.
NanoMedical Systems operates in the following industries: Biotechnology.
NanoMedical Systems has approximately 4 employees.
NanoMedical Systems has completed 4 funding rounds, raising a total of $10.21M. The latest funding stage is Grant.
Top alternatives and competitors to NanoMedical Systems include Thermosome, Drug Development & Delivery, ForDoz Pharma Corp, PreComb, National Drug Screening, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NanoMedical Systems and Thermosome are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NanoMedical Systems and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy